Raymond James & Associates Ptc Therapeutics, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 9,219 shares of PTCT stock, worth $416,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,219
Holding current value
$416,145
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$30.39 - $37.66 $280,165 - $347,187
9,219 New
9,219 $342,000
Q1 2023

Apr 14, 2023
SELL
$38.16 - $48.86 $108,717 - $139,202
-2,849 Reduced 35.47%
5,183 $251,000
Q4 2022

Feb 08, 2023
BUY
$33.53 - $54.79 $95,996 - $156,863
2,863 Added 55.39%
8,032 $306,000
Q3 2022

Oct 25, 2022
BUY
$41.85 - $53.85 $544 - $700
13 Added 0.25%
5,169 $259,000
Q2 2022

Aug 12, 2022
SELL
$25.6 - $45.23 $81,536 - $144,057
-3,185 Reduced 38.18%
5,156 $207,000
Q1 2022

May 11, 2022
BUY
$33.33 - $44.6 $41,429 - $55,437
1,243 Added 17.51%
8,341 $311,000
Q4 2021

Feb 08, 2022
SELL
$35.36 - $41.86 $954 - $1,130
-27 Reduced 0.38%
7,098 $283,000
Q3 2021

Nov 02, 2021
BUY
$37.01 - $44.74 $11,510 - $13,914
311 Added 4.56%
7,125 $265,000
Q2 2021

Aug 11, 2021
SELL
$37.95 - $49.37 $252,367 - $328,310
-6,650 Reduced 49.39%
6,814 $288,000
Q1 2021

May 14, 2021
BUY
$46.8 - $68.92 $140 - $206
3 Added 0.02%
13,464 $638,000
Q4 2020

Feb 12, 2021
SELL
$47.96 - $67.64 $372,313 - $525,089
-7,763 Reduced 36.58%
13,461 $822,000
Q3 2020

Nov 04, 2020
BUY
$45.41 - $57.07 $42,685 - $53,645
940 Added 4.63%
21,224 $992,000
Q2 2020

Jul 28, 2020
BUY
$42.56 - $54.98 $269,362 - $347,968
6,329 Added 45.35%
20,284 $1.03 Million
Q1 2020

Apr 21, 2020
BUY
$32.37 - $59.36 $222,932 - $408,812
6,887 Added 97.44%
13,955 $623,000
Q4 2019

Feb 12, 2020
BUY
$32.22 - $50.07 $1,385 - $2,153
43 Added 0.61%
7,068 $339,000
Q3 2019

Nov 07, 2019
SELL
$33.82 - $48.17 $141,942 - $202,169
-4,197 Reduced 37.4%
7,025 $238,000
Q2 2019

Aug 06, 2019
BUY
$35.42 - $45.0 $135,906 - $172,665
3,837 Added 51.96%
11,222 $505,000
Q4 2018

Feb 11, 2019
BUY
$29.83 - $46.51 $220,294 - $343,476
7,385 New
7,385 $253,000

Others Institutions Holding PTCT

# of Institutions
221
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.23B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email